Skip to main content

IRF3 inhibits IFN-γ-mediated restriction of intracellular pathogens in macrophages independently of IFNAR.

Publication ,  Conference
Maciag, K; Raychowdhury, R; Smith, K; Schneider, AM; Coers, J; Mumbach, MR; Schwartz, S; Hacohen, N
Published in: J Leukoc Biol
August 2022

Macrophages use an array of innate immune sensors to detect intracellular pathogens and to tailor effective antimicrobial responses. In addition, extrinsic activation with the cytokine IFN-γ is often required as well to tip the scales of the host-pathogen balance toward pathogen restriction. However, little is known about how host-pathogen sensing impacts the antimicrobial IFN-γ-activated state. It was observed that in the absence of IRF3, a key downstream component of pathogen sensing pathways, IFN-γ-primed macrophages more efficiently restricted the intracellular bacterium Legionella pneumophila and the intracellular protozoan parasite Trypanosoma cruzi. This effect did not require IFNAR, the receptor for Type I IFNs known to be induced by IRF3, nor the sensing adaptors MyD88/TRIF, MAVS, or STING. This effect also did not involve differential activation of STAT1, the major signaling protein downstream of both Type 1 and Type 2 IFN receptors. IRF3-deficient macrophages displayed a significantly altered IFN-γ-induced gene expression program, with up-regulation of microbial restriction factors such as Nos2. Finally, we found that IFN-γ-primed but not unprimed macrophages largely excluded the activated form of IRF3 from the nucleus following bacterial infection. These data are consistent with a relationship of mutual inhibition between IRF3 and IFN-γ-activated programs, possibly as a component of a partially reversible mechanism for modulating the activity of potent innate immune effectors (such as Nos2) in the context of intracellular infection.

Duke Scholars

Published In

J Leukoc Biol

DOI

EISSN

1938-3673

Publication Date

August 2022

Volume

112

Issue

2

Start / End Page

257 / 271

Location

England

Related Subject Headings

  • Trypanosoma cruzi
  • Nitric Oxide Synthase Type II
  • Macrophages
  • Legionella pneumophila
  • Interferon-gamma
  • Interferon Regulatory Factor-3
  • Immunology
  • Adaptor Proteins, Signal Transducing
  • 3204 Immunology
  • 1107 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Maciag, K., Raychowdhury, R., Smith, K., Schneider, A. M., Coers, J., Mumbach, M. R., … Hacohen, N. (2022). IRF3 inhibits IFN-γ-mediated restriction of intracellular pathogens in macrophages independently of IFNAR. In J Leukoc Biol (Vol. 112, pp. 257–271). England. https://doi.org/10.1002/JLB.3A0218-069RR
Maciag, Karolina, Raktima Raychowdhury, Karen Smith, Alexis M. Schneider, Jörn Coers, Maxwell R. Mumbach, Schraga Schwartz, and Nir Hacohen. “IRF3 inhibits IFN-γ-mediated restriction of intracellular pathogens in macrophages independently of IFNAR.” In J Leukoc Biol, 112:257–71, 2022. https://doi.org/10.1002/JLB.3A0218-069RR.
Maciag K, Raychowdhury R, Smith K, Schneider AM, Coers J, Mumbach MR, et al. IRF3 inhibits IFN-γ-mediated restriction of intracellular pathogens in macrophages independently of IFNAR. In: J Leukoc Biol. 2022. p. 257–71.
Maciag, Karolina, et al. “IRF3 inhibits IFN-γ-mediated restriction of intracellular pathogens in macrophages independently of IFNAR.J Leukoc Biol, vol. 112, no. 2, 2022, pp. 257–71. Pubmed, doi:10.1002/JLB.3A0218-069RR.
Maciag K, Raychowdhury R, Smith K, Schneider AM, Coers J, Mumbach MR, Schwartz S, Hacohen N. IRF3 inhibits IFN-γ-mediated restriction of intracellular pathogens in macrophages independently of IFNAR. J Leukoc Biol. 2022. p. 257–271.

Published In

J Leukoc Biol

DOI

EISSN

1938-3673

Publication Date

August 2022

Volume

112

Issue

2

Start / End Page

257 / 271

Location

England

Related Subject Headings

  • Trypanosoma cruzi
  • Nitric Oxide Synthase Type II
  • Macrophages
  • Legionella pneumophila
  • Interferon-gamma
  • Interferon Regulatory Factor-3
  • Immunology
  • Adaptor Proteins, Signal Transducing
  • 3204 Immunology
  • 1107 Immunology